Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
8.62
+0.02 (0.29%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $426.44 million as of April 17, 2025. Its market cap has decreased by -4.71% in one year.
Market Cap
426.44M
Enterprise Value
387.91M
1-Year Change
-4.71%
Ranking
Category
Stock Price
$8.62
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $426.44M, a decrease of -42.43%. That is a compound annual growth rate of -4.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 426.40M | -7.85% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 755.17B |
| UnitedHealth Group | 416.52B |
| Johnson & Johnson | 380.32B |
| AbbVie | 306.23B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |